One group of investigators found that ErbB2 protein expression was elevated in a large proportion of GBM samples and used ErbB2/HER2-specific NK cells to target GBM (16), proposing sustainably expanded “CAR-NK” cells—human NK cells that express ErbB2-specific chimeric antigen receptors. The gene discussed is ERBB2; the disease is glioblastoma.